期刊文献+

骨形态发生蛋白-2基因转染兔骨髓基质干细胞及复合纳米羟基磷灰石体外构建组织工程骨的研究 被引量:2

Rabbit bone marrow stromal cells transfeeted by adenovirus mediated bone morphogenetic protein-2 gene plus nano-hydroxyapatite to reconstruct tissue engineered bone in vitro
原文传递
导出
摘要 目的探讨腺病毒介导的人骨形态发生蛋白-2表达载体(Ad—BMP-2)转染兔骨髓基质干细胞(rBMSCs)后复合到纳米羟基磷灰石(Nano-HA)体外构建仿生人工骨的可行性。方法采用GatewayTM技术构建腺病毒载体,溶胶-絮凝法制备Nano-HA,用Ad—BMP-2转染体外培养的rBMSCs,免疫组化、RT—PCR和蛋白印迹方法检测转染后细胞的BMP-2表达。将转染48h的细胞均匀接种到Nano—HA支架上,第3、5天取细胞载体复合物扫描电镜观察细胞贴附、生长状况,消化收集贴附支架的细胞,蛋白印迹检测贴附支架细胞BMP-2的表达。结果转染后BMP-2基因在mRNA水平和蛋白水平均有高表达;扫描电镜见转染细胞在支架材料分布均匀,黏附良好,转染后及复合后Western Blot检测BMP-2表达较高。结论利用转基因技术,用含目的基因的腺病毒载体转染靶细胞复合到Nano—HA,细胞载体复合物稳定长效地分泌生长因子,体外成功地构建了仿生人工骨。 Objective To investigate the effects of adenovirus-mediated human bone morphogenetic protein-2 expression vector(Ad-BMP-2) transfected with rabbit bone marrow stromal cells(rBMSCs) plus nano-hydroxyapatite(Nano-HA) in reconstruction of biomimetic artificial bone in vitro. Methods The adenovirus vector was constructed by GatewayTM technology. Nano-HA was prepared by Sol-Flocculation. rBMSCs transfected by Ad-BMP-2 were cultured in vitro. Immunohistochemistry, RT-PCR and Western Blot were used to detect the BMP-2 expression in the transfeeted cells. After culture for 48 h, the transfected cells were seeded onto the Nano-HA scaffold. Scanning electron microscopy was used to observe the growth and attachment of cells on the composite scaffold on the third and fifth days. The attached cells were also gathered on the third and fifth days for detection of the BMP-2 expressions by Western Blot. Results After transfection, bBMP-2 gene showed high expressions in mRNA and protein levels. Scanning electron microscopy revealed even distribution and fine adherence of the cells in the composite scaffold. Western Blot showed high expression of BMP-2 in the transfected and compound cells. Conclusion The Ad-BMP-2 transfected with rBMSCs plus Nano-HA can successfully reconstruct the in vitro biomimetic artificial bone which can secrete growth factors stably.
出处 《中华创伤骨科杂志》 CAS CSCD 2010年第2期168-173,共6页 Chinese Journal of Orthopaedic Trauma
基金 深圳市卫生局科技计划项目(200630)
关键词 骨形态蛋白质类 骨髓细胞 组织工程 腺病毒载体 Bone morphogenetic proteins Bone marrow cells Tissue engineering Adenovirus vector
  • 相关文献

参考文献14

  • 1Evans CH, Ghivizzani SC, Robbins PD. Orthopaedic gene therapy. Clin Orthop Relat Res, 2004, (429): 316-329.
  • 2Rutherford RB, Moalli M, Franceschi RT, et al. Bone morphogenetic protein induced human fibroblast convert to osteoblasts and formation bone in vivo. Tissue Eng, 2002, 8: 441-452.
  • 3Santoni BG, Pluhar GE, Motta T, et al. Hollow calcium phosphate mieroearriers for bone regeneration: in vitro osteoproduction and ex vivo mechanical assessment. Biomed Mater Eng, 2007, 17: 277-289.
  • 4彭亮权,王大平,周可,黄俊锋,任凯,徐小平,陆伟,熊建义,欧阳侃,朱伟民.重组人骨形态发生蛋白2腺病毒载体的构建与鉴定[J].中国组织工程研究与临床康复,2009,13(20):3942-3946. 被引量:3
  • 5Hartman ZC, Appledorn DM, Amalfitano A. Adenovirus vector induced innate immune responses: Impact upon efficacy and toxicity in gene therapy and vaccine applications. Virus Res, 2008, 132: 1-14.
  • 6Wu D, Razzano P, Grande DA. Gene therapy and tissue engineering in repair of the musculoskeletal system. J Cell Biochem, 2003, 88: 467 -481.
  • 7张新生,刘小裕,任双义.绿色荧光蛋白的发现及其应用[J].大连医科大学学报,2009,31(4):342-344. 被引量:10
  • 8Yang ZR, Wang HF, Zhao J, et al. Recent developments in the use of adenoviruses and bone morphogenetic and immunotoxins in cancer gene therapy. Cancer Gene Ther, 2007, 14: 599-615.
  • 9彭亮权,王大平,何春耒,朱伟民,周可,谢礼涵,黄俊峰,徐小平,刘健全,欧阳侃.人骨髓间充质干细胞的分离、培养与鉴定[J].中国临床解剖学杂志,2009(3):321-324. 被引量:5
  • 10何春耒,王大平,马经野.骨组织工程支架材料的种类及发展趋势[J].中国组织工程研究与临床康复,2009,13(25):4905-4908. 被引量:7

二级参考文献44

共引文献29

同被引文献27

  • 1张阳德,乐园,赵梓屹.羟基磷灰石骨修复材料[J].中国现代医学杂志,2006,16(1):72-75. 被引量:16
  • 2罗庆平,刘桂香,杨世源,尹光福,郑昌琼.磷酸单酯偶联剂改性羟基磷灰石/高密度聚乙烯复合人工骨材料的制备和性能[J].复合材料学报,2006,23(1):80-84. 被引量:13
  • 3黄永辉,沈铁城,徐晓峰,左华,韩志强,田进.纳米羟基磷灰石/胶原骨修复骨缺损的效果评估[J].中国临床康复,2006,10(37):51-53. 被引量:19
  • 4Yamagiwa H,Endo N,Tokunaga K. In vivo bone-forming capacity of human bone marrow-derived stromal cells is stimulated by recombinant human bone morphogenetic protein-2[J].Journal of Bone and Mineral Metabolism,2001,(01):20-28.
  • 5Lee SJ. Cytokine delivery and tissue engineering[J].Yonsei Medical Journal,2000,(06):704-719.
  • 6Tsuchida H,Hashimoto J,Crawford E. Engineered allogeneic mesenchymal stem cells repair femoral segmental defectin rats[J].Journal of Orthopaedic Research,2003,(01):44-53.doi:10.1016/S0736-0266(02)00108-0.
  • 7Lieberman JR,DaluiskiA,Stevenson S. The effectof regional gene therapy with bone morphogenetic protein-2-producing bone-marrow cells on the repair of segmental femoral defects in rats[J].Journal of Bone and Joint Surgery-American Volume,1999,(07):905-917.
  • 8Mailly L,RenautL,Rogée S. Improved gene delivery to B lymphocytes using a modified adenovirus vectortargeting CD21[J].Molecular Therapy,2006,(02):293-304.doi:10.1016/j.ymthe.2006.03.017.
  • 9Lee FY,StorerS,Hazan EJ. Repair of bone allograft fracture using bone morphogenetic protein-2[J].Clinical Orthopaedics and Related Research,2002,(397):119-126.doi:10.1097/00003086-200204000-00017.
  • 10Santoni BG,Pluhar GE,Motta T. Hollow calcium phosphate microcarriers for bone regeneration:in vitro osteoproduction and ex vivo mechanical assessment[J].Biomedical Materials & Engineering,2007,(05):277-289.

引证文献2

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部